(Q41722635)

8 October 2017

title

Drug development for airway diseases: looking forward (English)

1 reference

8 October 2017

1

Stephen Holgate

1 reference

8 October 2017

8

Theodore F Reiss

1 reference

8 October 2017

Alvar Agusti

2

1 reference

8 October 2017

Robert M Strieter

3

1 reference

8 October 2017

Gary P Anderson

4

1 reference

8 October 2017

Robert Fogel

5

1 reference

8 October 2017

Elisabeth Bel

6

1 reference

8 October 2017

Thomas R Martin

7

1 reference

8 October 2017

publication date

22 May 2015

1 reference

Nature Reviews Drug Discovery

8 October 2017

published in

1 reference

8 October 2017

volume

14

1 reference

8 October 2017

issue

6

1 reference

8 October 2017

page(s)

367-368

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd4645

8 October 2017

exact match

0 references

cites work

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?

1 reference

Network analysis in the investigation of chronic respiratory diseases. From basics to application.

21 January 2018

1 reference

Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014

21 January 2018

1 reference

Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?

21 January 2018

1 reference

Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1038/NRD4645

1 reference

release_5dy76jo5zzbvrd3t33r4vfg6ce

8 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5dy76jo5zzbvrd3t33r4vfg6ce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference